Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Moleculin Biotech CS (MBRX)

1.52 +0.42 (+38.18%)

6/26/2017  4:00pm

Open:

1.25

Pre. Close:

1.10

High:

1.52

Low:

1.10

Volume:

5,544,160

Market Cap:

26.99M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-06-26 11:34:49 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 1.78     One year: 2.07

Support:

Support1: 1.02    Support2: 0.71

Resistance:

Resistance1: 1.52    Resistance2: 1.78

Pivot:

0.90

Moving Averages:

MA(5): 1.10     MA(20): 0.88

MA(100): 1.04     MA(250): 3.08

MACD:

MACD(12,26): 0.09     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 72.31     %D(3): 63.79

RSI:

RSI(14): 83.20

52-Week:

High: 7.36  Low: 0.71  Change(%): -77.8

Average Vol(K):

3-Month: 639  10-Days 2605

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
MBRX has closed above the upper band by 30.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 67.4% wider than normal. The large width of the bands suggest high volatility as compared to MBRX's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Thu, 02 Jun 2016 10:02:32 GMT
1.12

Mon, 26 Jun 2017 11:26:15 GMT
Moleculin Announces Scientific Support for Research Endeavor at Mayo Clinic

Wed, 21 Jun 2017 11:26:15 GMT
Moleculin Biotech (MBRX) Reports Significant Discovery with Potential to Treat ...

Wed, 28 Oct 2015 13:41:15 GMT
Moleculin Biotech, Inc. Announces Acquisition of Annamycin Rights

Thu, 22 Jun 2017 19:41:15 GMT
Checking the Overall Picture for Moleculin Biotech, Inc. (MBRX)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

17.76

Shares Float (M)

10.65

% Held by Insiders

% Held by Institutions

Shares Short (K)

940

Shares Short Prior Month (K)

948

Stock Financials

EPS

-0.333

EPS Est. Current Year

-0.340

EPS Est. Next Year

-0.360

EPS Est. Next Quarter

Forward EPS

-0.359

Book Value (p.s.)

1.230

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-4.87

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-4.56

P/E Growth Ratio

0.38

P/BV

1.24

P/S

P/CF

-5.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.